99%+ Purity
COA Included
Sealed Vials
ARA-290
Anti-inflammatory innate repair receptor agonist
Anti-inflammatory
Key Benefits
- May support natural tissue repair mechanisms
- Research suggests improved nerve regeneration potential
- May help reduce inflammatory cytokine activity
- Supports cellular survival and anti-apoptotic signaling
- May promote enhanced wound healing processes
- Research indicates neuropathic pain reduction potential
- May support improved glucose tolerance
Finally Stop Nerve Pain and Actually Heal the Damage
Most nerve pain treatments just mask symptoms while the underlying damage gets worse. ARA-290 flips this completely—it activates your body's natural repair mechanisms to actually regenerate damaged nerves and reduce inflammation at the source. You're not just managing pain anymore, you're reversing the damage that caused it.
Innate repair receptor (IRR) / JAK2-STAT3 cytoprotective signaling pathway
About ARA-290
ARA-290 is a selective tissue repair peptide that targets the innate repair receptor to promote genuine healing rather than just symptom management. It activates the same protective pathways your body uses naturally, but amplifies them significantly to accelerate nerve regeneration, reduce harmful inflammation, and improve overall tissue recovery.
Who It's For
Ideal for individuals dealing with neuropathic pain, diabetic complications, or chronic inflammatory conditions where conventional treatments have plateaued. This peptide works particularly well in comprehensive protocols focused on long-term tissue health rather than short-term symptom suppression. The goal is genuine repair and regeneration, making it valuable for those committed to addressing root causes rather than managing symptoms indefinitely.
Research Background
ARA-290 represents an innovative approach to tissue protection and repair by targeting the body's natural healing mechanisms without affecting red blood cell production. The peptide works through the innate repair receptor, a specialized cellular gateway that activates protective responses when tissues are damaged or inflamed. This mechanism is fundamentally different from traditional anti-inflammatory drugs, as ARA-290 doesn't simply suppress inflammation but instead promotes the body's own repair processes.
Research has focused on three primary areas: 1) neuropathic pain and nerve regeneration, where studies show promising results in diabetic nerve damage; 2) metabolic disorders, with evidence suggesting benefits for diabetes-related complications; and 3) tissue healing and repair, including wound healing and organ protection. The peptide's unique ability to activate repair pathways while reducing harmful inflammation makes it particularly attractive for conditions where current treatments only address symptoms rather than underlying tissue damage.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 10 mg/wk | |
Intermediate | 20 mg/wk | |
Advanced | 20-40 mg/wk | |
Maximum | 60 mg/wk |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
15
240.0 mg needed ÷ 16 per vial
Total Investment
$713
$47.50 per vial
Per Dose
2.50 mL
250 units on U-100 syringe
Doses per Vial
0
16 ÷ 20.00 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
ARA-290
$47.50